Home›People›Akihiro Ko
AK

Akihiro Ko

CEO and director at Elixirgen Therapeutics.

ExecutiveDirector
Updated Oct 27, 2026·Latest SEC filing Nov 13, 2025·Suggest an edit

About Akihiro Ko

Akihiro Ko is CEO and director at Elixirgen Therapeutics.

Akihiro Ko first appears on SEC filings in 2018.

Experience

This experience comes from SEC filings. The years are when the filings name Akihiro Ko in the role, so the role may have started earlier or lasted longer.

Elixirgen Therapeutics, Inc.
CEO and director
2018 – 2025 · Baltimore, MD

Key Colleagues at Startups

The people Akihiro Ko works with at each company, as listed on that company's latest Form D.

Elixirgen Therapeutics, Inc. · Form D, Nov 13, 2025
TW
Thomas White
Director
MK
Minoru Ko
Director
SC

Sources

  1. SECElixirgen Therapeutics, Inc. Form D, filed Nov 13, 2025